Literature DB >> 9567220

The HVJ liposome method.

Y Isaka1, Y Akagi, Y Kaneda, E Imai.   

Abstract

Recent advancement of gene technology allows us a practical approach to gene therapy. Among various in vivo gene transfer techniques available, the HVJ liposome method is an efficient procedure which could target the glomerular cells. Using this method, HVJ-mediated cell fusion activity enables us to introduce genetic materials directly into the cytosol without degradation. In addition, cointroduction of non-histone nuclear protein, high-mobility group (HMG-1), efficiently facilitates migration of foreign DNA to the nucleus. Although there still exist some limitations, the HVJ liposome method may be applicable to the treatment of glomerular diseases as well as to analysis of the molecular aspects of renal pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9567220     DOI: 10.1159/000020515

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  3 in total

Review 1.  Gene therapy for renal disorders: what are the benefits for the elderly?

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 2.  Renal gene transfer: nonviral approaches.

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

3.  Silencing genes in the kidney: antisense or RNA interference?

Authors:  Jia-Hui Wang; Bruce M Hendry; Claire C Sharpe
Journal:  Nephrol Dial Transplant       Date:  2008-03-07       Impact factor: 5.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.